MLAB
Mesa Laboratories Inc
137.50$
+3.4%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +16.4% | -39.8% | -1.4% | +3.1% | -3.7% | -0.9% | +0.6% | -1.2% | +1.0% | -1.6% | -2.0% | |
| – | +0.6% | -7.6% | -2.4% | +1.2% | +2.7% | -7.4% | -4.3% | -0.8% | +8.4% | +0.6% | -3.2% | |
| – | -20.8% | 0.0% | +0.9% | -14.5% | +27.2% | -11.7% | -22.1% | -4.0% | +41.9% | -7.1% | +14.0% | |
| – | -20.8% | 0.0% | +0.9% | -14.5% | +27.2% | -11.7% | -22.1% | -4.0% | +41.9% | -7.1% | +14.0% | |
| – | -0.9% | +8.4% | -8.9% | +13.1% | -3.9% | +8.6% | -6.9% | +2.6% | +0.4% | +9.6% | -22.0% | |
| – | +9.4% | -9.2% | -2.8% | -6.4% | -5.4% | -9.8% | +10.8% | -1.3% | -4.3% | -0.7% | +3.2% | |
| – | +22.2% | -48.0% | -0.2% | +2.2% | -3.6% | +2.6% | +3.5% | +0.2% | +0.4% | -1.3% | -0.4% | |
| – | +17.8% | -51.1% | -3.8% | -0.6% | -9.8% | -1.3% | +0.5% | -4.2% | -3.9% | -7.0% | -5.9% | |
| – | +35.8% | -11.0% | -3.9% | +1.0% | -3.7% | -3.0% | -3.8% | -4.3% | -1.5% | -2.7% | -4.6% | |
| – | +11.0% | +0.3% | +23.8% | +179.3% | +1.7% | +5.2% | -8.8% | -67.7% | +12.6% | +13.8% | -19.8% | |
| – | +12.6% | -4.8% | +124.0% | +1,458.6% | +0.2% | +0.1% | +0.8% | -91.9% | +6.4% | +2.9% | -11.4% | |
| – | -5.3% | +32.7% | -6.3% | +5.8% | -31.7% | +40.6% | +9.1% | -18.8% | +3.2% | -6.2% | +51.4% | |
| – | +36.4% | -4.8% | -6.0% | -50.0% | -9.0% | -18.9% | +3.4% | +114.0% | -5.4% | -9.4% | -5.9% | |
| – | +3.9% | -63.9% | +3.7% | +7.1% | -3.9% | +3.0% | +7.9% | +3.5% | +4.6% | -0.2% | +1.4% | |
| – | +1.8% | -355.0% | – | – | – | – | – | – | – | – | – | |
| – | +0.2% | 0.0% | +0.6% | +0.9% | -0.8% | +0.0% | +2.3% | -0.3% | +0.5% | -0.4% | +3.8% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.